Bullous pemphigoid in a patient with immunoglobulin A nephropathy
DOI:
https://doi.org/10.5070/ph1eq643Keywords:
antibody, autoimmune, bullous, IgA, Immunobullous, Nephropathy, PemphigoidAbstract
Bullous pemphigoid is a chronic autoimmune blistering disease typically presenting as non-specific pruritis following by the development of vesicles and bullae. A variety of medications and comorbid medical conditions have been associated with bullous pemphigoid. Herein, we present a case describing a potential novel association between immunoglobulin A nephropathy and bullous pemphigoid.
Downloads
References
1. Bernard P, Antonicelli F. Bullous pemphigoid: A review of its diagnosis, associations and treatment. Am J Clin Dermatol. 2017;18513-528. [PMID: 28378139].
2. Cui S, Zhang B, Li L. The relationship between bullous pemphigoid and renal disease and related treatments: A review of the current literature. Expert Rev Clin Immunol. 2023;19:1407-1417. [PMID: 37820713].
3. Chen TJ, Lai PC, Yang LC, et al. Bullous pemphigoid in a renal transplant recipient. Am J Clin Dermatol. 2009;10:197-200. [PMID: 19341394].
4. Fujisawa H, Ishii Y, Tateishi T, et al. Pemphigoid nodularis with IgA autoantibodies against the intracellular domain of desmoglein 1. Br J Dermatol. 2000;142:143-147. [PMID: 10651694].
5. Nishioka N, Nasu K, Hoshizaki H, et al. [Bullous pemphigoid associated with IgA nephropathy: A case report]. Nihon Naika Gakkai Zasshi. 1989;78:925-929. [PMID: 2688836].
6. Oya K, Watanabe R, Inoue S, et al. Bullous pemphigoid accompanied by IgA nephropathy and atypical haemolytic uraemic syndrome. Eur J Dermatol. 2018;28:421-422. [PMID: 29757958].
7. Hurskainen T, Moilanen J, Sormunen R, et al. Transmembrane collagen XVII is a novel component of the glomerular filtration barrier. Cell Tissue Res. 2012;348:579-588. [PMID: 22614829].
8. Moore RH, Hitman GA, Lucas EY, et al. HLA DQ region gene polymorphism associated with primary IgA nephropathy. Kidney Int. 1990;37:991-995. [PMID: 2319126].
9. Sernicola A, Mazzetto R, Tartaglia J, et al. Role of human leukocyte antigen class II in antibody-mediated skin disorders. Medicina. 2023;59:1950. [PMID: 37827015].
10. Ma SH, Wu CY, Lyu YS, et al. Association between sodium-glucose co-transporter 2 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A nationwide population-based cohort study. J Eur Acad Dermatol Venereol. 2022;36:1318-1324. [PMID: 35712762].
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Alex Marti, Owen Dean, Brittney Schultz, Sara Hylwa (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.